236 related articles for article (PubMed ID: 33690088)
1. The metastasizing mechanisms of lung cancer: Recent advances and therapeutic challenges.
Xie S; Wu Z; Qi Y; Wu B; Zhu X
Biomed Pharmacother; 2021 Jun; 138():111450. PubMed ID: 33690088
[TBL] [Abstract][Full Text] [Related]
2. Epithelial Mesenchymal Transition in Aggressive Lung Cancers.
Mittal V
Adv Exp Med Biol; 2016; 890():37-56. PubMed ID: 26703798
[TBL] [Abstract][Full Text] [Related]
3. Roles of exosomes in the carcinogenesis and clinical therapy of non-small cell lung cancer.
Liu S; Zhan Y; Luo J; Feng J; Lu J; Zheng H; Wen Q; Fan S
Biomed Pharmacother; 2019 Mar; 111():338-346. PubMed ID: 30590322
[TBL] [Abstract][Full Text] [Related]
4. Epithelial-Mesenchymal Transition Is Associated with a Distinct Tumor Microenvironment Including Elevation of Inflammatory Signals and Multiple Immune Checkpoints in Lung Adenocarcinoma.
Lou Y; Diao L; Cuentas ER; Denning WL; Chen L; Fan YH; Byers LA; Wang J; Papadimitrakopoulou VA; Behrens C; Rodriguez JC; Hwu P; Wistuba II; Heymach JV; Gibbons DL
Clin Cancer Res; 2016 Jul; 22(14):3630-42. PubMed ID: 26851185
[TBL] [Abstract][Full Text] [Related]
5. The Microenvironment of Lung Cancer and Therapeutic Implications.
Mittal V; El Rayes T; Narula N; McGraw TE; Altorki NK; Barcellos-Hoff MH
Adv Exp Med Biol; 2016; 890():75-110. PubMed ID: 26703800
[TBL] [Abstract][Full Text] [Related]
6. The role of the tumor-microenvironment in lung cancer-metastasis and its relationship to potential therapeutic targets.
Wood SL; Pernemalm M; Crosbie PA; Whetton AD
Cancer Treat Rev; 2014 May; 40(4):558-66. PubMed ID: 24176790
[TBL] [Abstract][Full Text] [Related]
7. PHD3 Controls Lung Cancer Metastasis and Resistance to EGFR Inhibitors through TGFα.
Dopeso H; Jiao HK; Cuesta AM; Henze AT; Jurida L; Kracht M; Acker-Palmer A; Garvalov BK; Acker T
Cancer Res; 2018 Apr; 78(7):1805-1819. PubMed ID: 29339541
[TBL] [Abstract][Full Text] [Related]
8. Silencing of RAD51AP1 suppresses epithelial-mesenchymal transition and metastasis in non-small cell lung cancer.
Wu Y; Wang H; Qiao L; Jin X; Dong H; Wang Y
Thorac Cancer; 2019 Sep; 10(9):1748-1763. PubMed ID: 31317661
[TBL] [Abstract][Full Text] [Related]
9. Novel ADAM-17 inhibitor ZLDI-8 inhibits the proliferation and metastasis of chemo-resistant non-small-cell lung cancer by reversing Notch and epithelial mesenchymal transition in vitro and in vivo.
Lu HY; Zu YX; Jiang XW; Sun XT; Liu TY; Li RL; Wu Q; Zhang YS; Zhao QC
Pharmacol Res; 2019 Oct; 148():104406. PubMed ID: 31442576
[TBL] [Abstract][Full Text] [Related]
10. LFG-500, a novel synthetic flavonoid, suppresses epithelial-mesenchymal transition in human lung adenocarcinoma cells by inhibiting NLRP3 in inflammatory microenvironment.
Yang D; Cao X; Wang F; Jiang H; Feng D; Guo H; Du L; Jin Y; Chen Y; Yin X; Li C
Cancer Lett; 2017 Aug; 400():137-148. PubMed ID: 28461245
[TBL] [Abstract][Full Text] [Related]
11. Biomarker discovery in highly invasive lung cancer cell through proteomics approaches.
Kuo CH; Lin MW; Hsu YW; Chou HC; Lin LH; Law CH; Lin YC; Hu RY; Kuo WH; Ko ML; Chang SJ; Lee YR; Chan HL
Cell Biochem Funct; 2021 Apr; 39(3):367-379. PubMed ID: 33135206
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of microRNA-137 expression by Slug promotes tumor invasion and metastasis of non-small cell lung cancer cells through suppression of TFAP2C.
Chang TH; Tsai MF; Gow CH; Wu SG; Liu YN; Chang YL; Yu SL; Tsai HC; Lin SW; Chen YW; Kuo PY; Yang PC; Shih JY
Cancer Lett; 2017 Aug; 402():190-202. PubMed ID: 28610956
[TBL] [Abstract][Full Text] [Related]
13. MircoRNA-33a inhibits epithelial-to-mesenchymal transition and metastasis and could be a prognostic marker in non-small cell lung cancer.
Yang L; Yang J; Li J; Shen X; Le Y; Zhou C; Wang S; Zhang S; Xu D; Gong Z
Sci Rep; 2015 Sep; 5():13677. PubMed ID: 26330060
[TBL] [Abstract][Full Text] [Related]
14. MTA1 promotes epithelial to mesenchymal transition and metastasis in non-small-cell lung cancer.
Ma K; Fan Y; Dong X; Dong D; Guo Y; Wei X; Ning J; Geng Q; Wang C; Hu Y; Li M; Niu W; Li E; Wu Y
Oncotarget; 2017 Jun; 8(24):38825-38840. PubMed ID: 28418915
[TBL] [Abstract][Full Text] [Related]
15. Endothelium and cancer metastasis: Perspectives for antimetastatic therapy.
Blazejczyk A; Papiernik D; Porshneva K; Sadowska J; Wietrzyk J
Pharmacol Rep; 2015 Aug; 67(4):711-8. PubMed ID: 26321272
[TBL] [Abstract][Full Text] [Related]
16. Sulforaphane suppresses EMT and metastasis in human lung cancer through miR-616-5p-mediated GSK3β/β-catenin signaling pathways.
Wang DX; Zou YJ; Zhuang XB; Chen SX; Lin Y; Li WL; Lin JJ; Lin ZQ
Acta Pharmacol Sin; 2017 Feb; 38(2):241-251. PubMed ID: 27890917
[TBL] [Abstract][Full Text] [Related]
17. The lung microenvironment: an important regulator of tumour growth and metastasis.
Altorki NK; Markowitz GJ; Gao D; Port JL; Saxena A; Stiles B; McGraw T; Mittal V
Nat Rev Cancer; 2019 Jan; 19(1):9-31. PubMed ID: 30532012
[TBL] [Abstract][Full Text] [Related]
18. Twist may be associated with invasion and metastasis of hypoxic NSCLC cells.
Wei L; Sun JJ; Cui YC; Jiang SL; Wang XW; Lv LY; Xie L; Song XR
Tumour Biol; 2016 Jul; 37(7):9979-87. PubMed ID: 26819207
[TBL] [Abstract][Full Text] [Related]
19. Tumor-stromal interactions in lung cancer: novel candidate targets for therapeutic intervention.
El-Nikhely N; Larzabal L; Seeger W; Calvo A; Savai R
Expert Opin Investig Drugs; 2012 Aug; 21(8):1107-22. PubMed ID: 22667993
[TBL] [Abstract][Full Text] [Related]
20. Emerging functional markers for cancer stem cell-based therapies: Understanding signaling networks for targeting metastasis.
Marquardt S; Solanki M; Spitschak A; Vera J; Pützer BM
Semin Cancer Biol; 2018 Dec; 53():90-109. PubMed ID: 29966677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
